Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP395223.RAA30r_jFdL5N6jd1-GvfAgfGGBs-AAYw0CVcScLEV21Y130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP395223.RAA30r_jFdL5N6jd1-GvfAgfGGBs-AAYw0CVcScLEV21Y130_assertion type Assertion NP395223.RAA30r_jFdL5N6jd1-GvfAgfGGBs-AAYw0CVcScLEV21Y130_head.
- NP395223.RAA30r_jFdL5N6jd1-GvfAgfGGBs-AAYw0CVcScLEV21Y130_assertion wasGeneratedBy ECO_0000203 NP395223.RAA30r_jFdL5N6jd1-GvfAgfGGBs-AAYw0CVcScLEV21Y130_provenance.
- NP395223.RAA30r_jFdL5N6jd1-GvfAgfGGBs-AAYw0CVcScLEV21Y130_assertion wasDerivedFrom befree-20140225 NP395223.RAA30r_jFdL5N6jd1-GvfAgfGGBs-AAYw0CVcScLEV21Y130_provenance.
- NP395223.RAA30r_jFdL5N6jd1-GvfAgfGGBs-AAYw0CVcScLEV21Y130_assertion SIO_000772 15930345 NP395223.RAA30r_jFdL5N6jd1-GvfAgfGGBs-AAYw0CVcScLEV21Y130_provenance.
- NP395223.RAA30r_jFdL5N6jd1-GvfAgfGGBs-AAYw0CVcScLEV21Y130_assertion evidence source_evidence_literature NP395223.RAA30r_jFdL5N6jd1-GvfAgfGGBs-AAYw0CVcScLEV21Y130_provenance.
- NP395223.RAA30r_jFdL5N6jd1-GvfAgfGGBs-AAYw0CVcScLEV21Y130_assertion description "[At three gene loci (GSTP1, APC, and PTGS1) and CpG island, hypermethylation was highly prevalent in prostate cancers (71-91%), and analysis of receiver operator curves showed that hypermethylation at these three gene loci can distinguish between prostate cancer and noncancerous prostatic tissue (i.e., benign hyperplasia) with a sensitivity of 71.1% to 96.2% and a specificity of 92.9% to 100%.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP395223.RAA30r_jFdL5N6jd1-GvfAgfGGBs-AAYw0CVcScLEV21Y130_provenance.